Welcome to the Investor Relations section of the GW Pharmaceuticals website.
This area is dedicated to keeping shareholders and potential investors up to date with share price, news and other relevant information.
+ 1.27 (+1.06%)
29/03/2017 - 4:00 PM
Mar 29, 2017
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Drug Designation from the European Medicines Agency for the Treatment of Lennox-Gastaut Syndrome
Mar 7, 2017
GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director - UK
Mar 2, 2017
GW Pharmaceuticals to Present at the Cowen and Company 37th Annual Healthcare Conference on Wednesday, 8 March, 2017